Checkpoint inhibitor‐based salvage regimens prior to autologous stem cell transplant improve event‐free survival in relapsed/refractory classic Hodgkin lymphoma
暂无分享，去创建一个
R. Advani | S. Ansell | K. Dorritie | V. Bachanova | Raya Saba | G. Nowakowski | G. Goyal | H. Shah | S. Arai | B. Kahl | C. Diefenbach | Y. Choi | V. Kenkre | Nuttavut Sumransub | M. Spinner | J. Azzi | U. Ibrahim | K. David | H. Hatic | Rahul Mishra | V. Orellana-Noia | Cheryl Chang | Elyse I. Harris | K. Rappazzo | Sanjal H. Desai | Ivana N. Micallef | Brendon Fusco | Jacob Murphy | Deepa Jagadish | Siddharth Iyenger | E. Harris | N. Sumransub | B. Fusco